Discover how scientists are using fucose-truncated Ipomoeassin F analogues to disrupt cancer cell protein transport and develop innovative cancer treatments.
Exploring Michael Shuler's revolutionary Body-on-a-Chip technology and its impact on drug development and biomedical research